Toll Free: 1-888-928-9744

KunWha Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

KunWha Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'KunWha Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the KunWha Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of KunWha Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of KunWha Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of KunWha Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the KunWha Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate KunWha Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of KunWha Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the KunWha Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of KunWha Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of KunWha Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of KunWha Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
KunWha Pharmaceutical Co., Ltd. Snapshot 5
KunWha Pharmaceutical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
KunWha Pharmaceutical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
KunWha Pharmaceutical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
KunWha Pharmaceutical Co., Ltd. - Pipeline Products Glance 12
KunWha Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Phase III Products/Combination Treatment Modalities 13
KunWha Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 14
Phase I Products/Combination Treatment Modalities 14
KunWha Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15
Discovery Products/Combination Treatment Modalities 15
KunWha Pharmaceutical Co., Ltd. - Drug Profiles 16
fentanyl citrate 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
pregabalin ER 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
sarpogrelate SR 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
KW-21072 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
KW-21097 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
KunWha Pharmaceutical Co., Ltd. - Pipeline Analysis 21
KunWha Pharmaceutical Co., Ltd. - Pipeline Products by Target 21
KunWha Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 22
KunWha Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 23
KunWha Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 24
KunWha Pharmaceutical Co., Ltd. - Recent Pipeline Updates 25
KunWha Pharmaceutical Co., Ltd. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28
List of Tables
KunWha Pharmaceutical Co., Ltd., Key Information 5
KunWha Pharmaceutical Co., Ltd., Key Facts 5
KunWha Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014 7
KunWha Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 8
KunWha Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9
KunWha Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014 10
KunWha Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
KunWha Pharmaceutical Co., Ltd. - Pre-Registration, 2014 12
KunWha Pharmaceutical Co., Ltd. - Phase III, 2014 13
KunWha Pharmaceutical Co., Ltd. - Phase I, 2014 14
KunWha Pharmaceutical Co., Ltd. - Discovery, 2014 15
KunWha Pharmaceutical Co., Ltd. - Pipeline by Target, 2014 21
KunWha Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014 22
KunWha Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014 23
KunWha Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 24
KunWha Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014 25
KunWha Pharmaceutical Co., Ltd., Other Locations 26 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify